TRISHA WELSH: Open Payments
NPI 1710318373 · CEDAR RAPIDS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$679 in 44 payments from 10 companies in 2025. Trend: 2023 $15 · 2024 $44 · 2025 $679
Food & beverage: $679
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $203 |
| PFIZER INC. | 12 | $175 |
| Sumitomo Pharma America, Inc. | 3 | $63 |
| Lilly USA, LLC | 3 | $53 |
| Novo Nordisk Inc | 3 | $53 |
| Astellas Pharma US Inc | 2 | $51 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| CooperSurgical, Inc. | 1 | $16 |
| Boston Scientific Corporation | 1 | $9 |
Products named: NURTEC ODT, VRAYLAR, Wegovy, Veozah, JOURNAVX, GEMTESA, ZEPBOUND, MYFEMBREE.
Industry payments across IA — which companies pay providers there.
